Prithvi Mruthyunjaya MD, MHS

Prithvi Mruthyunjaya MD, MHS is a Professor of Ophthalmology and Associate Professor of Radiation Oncology (by courtesy) at Stanford University, Director of Ocular Oncology at the Byers Eye Institute, and a member of the Vitreoretinal Surgery Service. He is a board certified ophthalmologist who has completed two prestigious fellowships: the first in Vitreoretinal Surgery at Duke University and the second in Ocular Oncology at Moorfields Eye Hospital in London, England.

He cares for patients with conditions related to cancer of the eye in both adults and children--either benign, pre-cancerous, or malignant. These conditions include ocular melanoma, hemangioma, cancers from other parts of the body that spread to the eye, Coats' disease, retinoblastoma, iris tumors (melanoma, cysts, metastatic lesions), and tumors of the conjunctiva including melanoma, and squamous cells carcinoma. He also manages the eye-related side effects of chemotherapy treatments. He is an expert in using the most advanced diagnostic tests to make a personalized treatment plan for every patient. With his expertise in retinal surgery, he treats patients with a variety of advanced techniques including small-instrument tumor biopsy, vitrectomy, and radiation therapy. His approach to any patient is to provide customized care for every patient and works closely with other experts at the Stanford Cancer Institute.

As a retinal surgeon, he manages complicated retinal diseases including retinal detachment, macular holes, epiretinal membranes, and diabetic eye disease.

Dr. Mruthyunjaya is actively involved in research in ocular cancer imaging, genetics, and new modalities of tumor biopsy. He actively participates in early-phase clinical trial development in ocular oncology and has brought cutting-edge treatment options to his patients at Stanford. He has published extensively in the field of ocular oncology, ophthalmic imaging, and complex retinal surgery. In addition, he holds leadership positions in the American Academy of Ophthalmology (AAO), the Retina Society, and the International Society of Ocular Oncology.

His passion lies in developing collaborative research networks and training the next generation of vitreoretinal surgeons. He serves as the Vitreoretinal Surgery Fellowship Director at Stanford. His academic contributions were recognized by the Heed, AOS-Knapp, and Ronald G. Michels foundations and the American Society of Retina Specialists with their Senior Honor Award. He has received the Senior Achievement and Secretariat Award from the American Academy of Ophthalmology. He was recently listed as one of the world's 150 most innovative retinal specialists and is a 2022 inductee in the Global Retinal Hall of Fame.